Biosimilars: An Opportunity to Update the Product Information of Biological Drugs Regarding their Immunogenicity.
Rodrigo BorregaJoao Paulo CruzPeter TaylorJoao GoncalvesPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2020)